Prime medicine presents first-ever prime editing data in non-human primates demonstrating highly efficient ability of prime editors to precisely correct disease-causing mutation of gsd1b

Up to 83% of hepatocytes (up to 50% whole liver) precisely edited for p.l358fs mutation following iv infusion of prime editor in nhps with no safety concerns observed; editing well above anticipated threshold necessary to reverse disease manifestations
PRME Ratings Summary
PRME Quant Ranking